Introduction: The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use released the ICH M10 Bioanalytical Method […]
ICH M10 Bioanalytical Method Validation Guidelines: What Drug Developers Need to Know Read More »
Introduction: Octreotide PLGA Characterization plays a pivotal role in the development and regulatory approval of generic long-acting injectable depots. For
Introduction: Toxicological Assessment in Extractables & Leachables Studies is a critical scientific process used to evaluate whether chemical compounds migrating
Introduction: Reverse Engineering Risperidone PLGA Microspheres is a critical approach in modern pharmaceutical development, particularly for long-acting injectable formulations. By
Summary: Dulaglutide Sameness Study is a comprehensive analytical comparison demonstrating that a proposed generic dulaglutide product is structurally and chemically
Introduction: Exenatide PLGA Microsphere Characterization plays a pivotal role in the development of long-acting injectable formulations, particularly for GLP-1 analogs
Introduction: Active Ingredient Characterization for ANDA submission is a fundamental requirement to establish that the generic product matches the reference
How to Characterize Active Ingredients in Finished Dosage Forms for ANDA Read More »
Summary: 1. Introduction A Retatrutide Sameness Study is the mandatory analytical validation required to prove that a generic synthetic peptide
Summary: A Tirzepatide Sameness Study is the scientific backbone of a successful generic Abbreviated New Drug Application (ANDA). This report
Introduction: Peptide Characterization for ANDA submission is a critical regulatory requirement to demonstrate that a generic peptide drug is equivalent
Peptide Characterization Requirements for ANDA Approval Read More »
